2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

For many years, bleeding has been perceived as an unavoidable consequence of strategies
aimed at reducing thrombotic complications in patients undergoing percutaneous coronary …

Perioperative cardiovascular complications are important causes of morbidity and mortality
associated with non-cardiac surgery, particularly in patients with coronary artery disease …

Dual antiplatelet therapy with aspirin and the oral P2Y12 inhibitor clopidogrel as the
cornerstone of treatment for patients with an acute coronary syndrome (ACS) undergoing …

Aims The endogenous fibrinolytic system serves to prevent lasting thrombotic occlusion and
infarction following initiation of coronary thrombosis. We aimed to determine whether …

Triglyceride glycemic-body mass index (TyG-BMI) is a simple and reliable surrogate for
insulin resistance (IR). However, it is still unclear if TyG-BMI has any predictive value in …

Background Early P2Y 12 inhibitor monotherapy has emerged as a promising alternative to
12 months of dual antiplatelet therapy following percutaneous coronary intervention (PCI) …

Aims Emerging evidence has linked cholesterol metabolism with platelet responsiveness.
We sought to examine the dose–response relationship between low-density lipoprotein …

Background Elderly patients have high ischemic and bleeding rates after acute coronary
syndrome; however, the occurrence of these complications over time has never been …

Aims Nutrition is an important determinant of health above the age of 80 years. Malnutrition
in the elderly is often underdiagnosed. The aim of this study was to report the prevalence …